BioMed Research International
Volume 2017 (2017), Article ID 4529437, 1 page
https://doi.org/10.1155/2017/4529437

Corrigendum

Corrigendum to “Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy”

Han Yuen Lam,¹ Swee Keong Yeap,² Mehdi R. Pirozyan,² Abdul Rahman Omar,² Khatijah Yusoff,³ Suraini Abd-Aziz,⁴ and Noorjahan Banu Alitheen¹

¹Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
²Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
³Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
⁴Department of Bioprocess Technology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia

Correspondence should be addressed to Noorjahan Banu Alitheen; noorjahan@upm.edu.my

Received 2 November 2016; Accepted 25 September 2017; Published 3 December 2017

Copyright © 2017 Han Yuen Lam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy” [1] the name of the third author was given incorrectly as Mehdi Rasoli. The author’s name should have been written as Mehdi R. Pirozyan. In addition, the first and last names of the sixth author were reversed. The revised authors’ list is shown above.

References

H. Y. Lam, S. K. Yeap, M. Rasoli et al., “Safety and clinical usage of newcastle disease virus in cancer therapy,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 718710, 2011.